PTX3 and chronic kidney disease: The majority of study participants exhibited a severe elevation of PTX3 (>4.5 ng/ml) with 31 (51.67%) CKD patients, followed by moderate elevation in PTX3 values seen in 17 (28.33%) participants, and the rest (12; 20%) fell into the mild elevation category.